Home - Products - MAPK/ERK Signaling - p38 MAPK - methyl 5-(3,4-dimethoxyphenyl)isoxazole-3-carboxylate

methyl 5-(3,4-dimethoxyphenyl)isoxazole-3-carboxylate

CAS No. 517870-17-6

methyl 5-(3,4-dimethoxyphenyl)isoxazole-3-carboxylate( —— )

Catalog No. M24490 CAS No. 517870-17-6

methyl 5-(3,4-dimethoxyphenyl)isoxazole-3-carboxylate targets MAPK.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
10MG 29 In Stock
25MG 51 In Stock
50MG 75 In Stock
100MG 112 In Stock
200MG 168 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    methyl 5-(3,4-dimethoxyphenyl)isoxazole-3-carboxylate
  • Note
    Research use only, not for human use.
  • Brief Description
    methyl 5-(3,4-dimethoxyphenyl)isoxazole-3-carboxylate targets MAPK.
  • Description
    methyl 5-(3,4-dimethoxyphenyl)isoxazole-3-carboxylate targets MAPK.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    p38 MAPK
  • Recptor
    MAPK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    517870-17-6
  • Formula Weight
    263.25
  • Molecular Formula
    C13H13NO5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    COC1=C(C=C(C=C1)C2=CC(=NO2)C(=O)OC)OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Pardoprunox hydrochl...

    Pardoprunox hydrochloride is a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.

  • Veraguensin

    Veraguensin is derived from Magnolia sp.. Veraguensin inhibits bone resorption and shows high antileishmanial activity.

  • RWJ 67657

    A potent, selective, orally active p38 MAPK inhibitor that inhibits the production of TNF-α and IL-1β by LPS-stimulated human PBMCs with IC50 of 3 and 11 nM, respectively.